Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Singer

Showing results (91-100 of 313) with videos related to

Pageof 32
Sort By:
Archives of Internal Medicine|March 8, 2003
Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosisElaine M Hylek, Susan Regan, Lori E Henault, et al.
Journal of the American Geriatrics Society|January 1, 2017
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic StrokeEmer R McGrath, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology|October 24, 2015
Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care DatabaseHendrika A van den Ham, Olaf H Klungel, Daniel E Singer, et al.
Journal of the American College of Cardiology|January 23, 2016
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Stroke|April 28, 2012
Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulantsMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
JAMA Neurology|August 15, 2018
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysisWen-Yi Huang, Daniel E Singer, Yi-Ling Wu, et al.
Pageof 32

Showing results (91-100 of 313) with videos related to

Sort By:
Pageof 32
Archives of Internal Medicine|March 8, 2003
Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosisElaine M Hylek, Susan Regan, Lori E Henault, et al.
Journal of the American Geriatrics Society|January 1, 2017
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic StrokeEmer R McGrath, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology|October 24, 2015
Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care DatabaseHendrika A van den Ham, Olaf H Klungel, Daniel E Singer, et al.
Journal of the American College of Cardiology|January 23, 2016
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Stroke|April 28, 2012
Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulantsMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
JAMA Neurology|August 15, 2018
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysisWen-Yi Huang, Daniel E Singer, Yi-Ling Wu, et al.
Pageof 32